{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:53:26Z","timestamp":1784026406707,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.canlet.2011.08.029","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T08:57:45Z","timestamp":1315645065000},"page":"99-107","source":"Crossref","is-referenced-by-count":16,"title":["Toxicity and delivery methods for the linamarase\/linamarin\/glucose oxidase system, when used against human glioma tumors implanted in the brain of nude rats"],"prefix":"10.1016","volume":"313","author":[{"given":"Willie","family":"Girald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2011.08.029_b0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.21793","article-title":"Molecularly targeted therapies for glioma","volume":"66","author":"Yamanaka","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.canlet.2011.08.029_b0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10143-009-0189-1","article-title":"Dendritic-cell-and peptide-based vaccination strategies for glioma","volume":"32","author":"Yamanaka","year":"2009","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.canlet.2011.08.029_b0015","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2165\/11538040-000000000-00000","article-title":"Drug or vaccine?: selecting the appropriate treatment for malignant glioma patients","volume":"70","author":"Dai","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.canlet.2011.08.029_b0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00130404-200305000-00006","article-title":"Gene therapy for human malignant brain tumors","volume":"9","author":"Rainov","year":"2003","journal-title":"Cancer J."},{"key":"10.1016\/j.canlet.2011.08.029_b0025","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00019052-200312000-00004","article-title":"Advances in gene therapy and immunotherapy for brain tumors","volume":"16","author":"Kew","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.canlet.2011.08.029_b0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ymthe.2005.07.357","article-title":"Gene therapy for malignant glioma: current clinical status","volume":"12","author":"Pulkkanen","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2011.08.029_b0035","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bjc.1994.400","article-title":"Targeting enzymes for cancer therapy: old enzymes in new roles","volume":"70","author":"Deonarain","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2011.08.029_b0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jgm.280","article-title":"Cyanide bystander effect of the linamarase\/linamarin killer-suicide gene therapy system","volume":"4","author":"Cortes","year":"2002","journal-title":"J. Gene Med."},{"key":"10.1016\/j.canlet.2011.08.029_b0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1104\/pp.93.1.176","article-title":"Purification, characterization, and localization of linamarase in cassava","volume":"93","author":"Mkpong","year":"1990","journal-title":"Plant Physiol."},{"key":"10.1016\/j.canlet.2011.08.029_b0050","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0022-3565(25)39464-4","article-title":"Preclinical safety studies of glucose oxidase","volume":"266","author":"Samoszuk","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.canlet.2011.08.029_b0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1158\/1541-7786.MCR-07-0243","article-title":"Glioma regression in vitro and in vivo by a suicide combined treatment","volume":"6","author":"Garcia-Escudero","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2011.08.029_b0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4161\/auto.7.5.14731","article-title":"Therapy mediated by mitophagy abrogates tumor progression","volume":"7","author":"Gargini","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2011.08.029_b0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2009.08.016","article-title":"The adenovirus-mediated linamarase\/linamarin suicide system: a potential strategy for the treatment of hepatocellular carcinoma","volume":"289","author":"Li","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2011.08.029_b0070","first-page":"252","article-title":"Drug delivery to the central nervous system: a review","volume":"6","author":"Misra","year":"2003","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.canlet.2011.08.029_b0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00174616","article-title":"Non-adaptive cellular immune responses as studied in euthymic and athymic nude rats. Spontaneous rejection of allogeneic lymphoid cell grafts by natural killer (NK) cells","volume":"181","author":"Rolstad","year":"1990","journal-title":"Anat. Embryol. (Berlin)"},{"key":"10.1016\/j.canlet.2011.08.029_b0080","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1097\/00007890-199612270-00042","article-title":"T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection","volume":"62","author":"Candinas","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.canlet.2011.08.029_b0085","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1097\/00007890-199712270-00008","article-title":"Contribution of activated macrophages to the process of delayed xenograft rejection","volume":"64","author":"Lin","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.canlet.2011.08.029_b0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0163-7258(03)00014-7","article-title":"Current and future strategies for the treatment of malignant brain tumors","volume":"98","author":"Castro","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2011.08.029_b0095","first-page":"491","article-title":"Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)\/ganciclovir gene therapy","volume":"3","author":"Izquierdo","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2011.08.029_b0100","doi-asserted-by":"crossref","first-page":"e6314","DOI":"10.1371\/journal.pone.0006314","article-title":"Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy","volume":"4","author":"Huszthy","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2011.08.029_b0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/S1807-59322010000300011","article-title":"Xenograft transplantation of human malignant astrocytoma cells into immunodeficient rats: an experimental model of glioblastoma","volume":"65","author":"Miura","year":"2010","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.canlet.2011.08.029_b0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1010620420241","article-title":"Migration pathways of human glioblastoma cells xenografted into the immunosuppressed rat brain","volume":"52","author":"Guillamo","year":"2001","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.canlet.2011.08.029_b0115","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.expneurol.2004.08.015","article-title":"Spontaneous regression of experimental gliomas \u2013 an immunohistochemical and MRI study of the C6 glioma spheroid implantation model","volume":"190","author":"Vince","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.canlet.2011.08.029_b0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0090-1229(80)90033-1","article-title":"The athymic nude rat. II. Immunological characteristics","volume":"15","author":"Vos","year":"1980","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.canlet.2011.08.029_b0125","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bjc.1982.122","article-title":"Human tumour xenografts in athymic rats and their age dependence","volume":"45","author":"Maruo","year":"1982","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2011.08.029_b0130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.6004\/jnccn.2005.0042","article-title":"Local treatment of malignant brain tumors using implantable chemotherapeutic polymers","volume":"3","author":"Gallia","year":"2005","journal-title":"J. Natl. Comp. Cancer Netw."},{"key":"10.1016\/j.canlet.2011.08.029_b0135","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/jnci\/djm027","article-title":"Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin","volume":"99","author":"Tang","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2011.08.029_b0140","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1158\/0008-5472.CAN-03-3631","article-title":"Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging","volume":"64","author":"Saito","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.08.029_b0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF01060219","article-title":"Implantable pumps for drug delivery to the brain","volume":"26","author":"Bakhshi","year":"1995","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.canlet.2011.08.029_b0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","article-title":"Delivery of therapeutic agents to the central nervous system: the problems and the possibilities","volume":"104","author":"Begley","year":"2004","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.canlet.2011.08.029_b0155","article-title":"Microglia in close vicinity of glioma cells: correlation between phenotype and metabolic alterations","volume":"2","author":"Pierre Voisin","year":"2010","journal-title":"Front Neuroenerget."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351100526X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351100526X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T10:57:45Z","timestamp":1741604265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438351100526X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S030438351100526X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2011.08.029","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}